Literature DB >> 17203107

Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.

P Bastone1, F Romen, W Liu, R Wirtz, U Koch, N Josephson, S Langbein, M Löchelt.   

Abstract

As serious side effects affected recent virus-mediated gene transfer studies, novel vectors with improved safety profiles are urgently needed. In the present study, replication-deficient retroviral vectors based on feline foamy virus (FFV) were constructed and analyzed. The novel FFV vectors are devoid of almost the complete env gene plus the internal promoter - accessory bel gene cassette including the gene for the viral transcriptional transactivator Bel1/Tas. In these Bel1/Tas-independent vectors, expression of the lacZ (beta-galactosidase) marker gene is directed by the heterologous, constitutively active human ubiquitin C promoter (ubi). Env-transcomplemented vectors have un-concentrated titers of more than 10(5) transducing units/ml. The vectors allow efficient transduction of a broad array of diverse target cells, which can be increased by repeated vector exposure. However, the number of lacZ marker gene expressing cells decreased slightly upon serial passages of the transduced cells. Vectors carrying a self-inactivating (SIN) deletion of the TATA box and most parts of the viral promoter were not rescued by wt FFV whereas those with the intact or a partially deleted promoter were readily reactivated. This finding indicates that the viral promoters are in fact non-functional, pointing to a highly advantageous safety profile of these new FFV-ubi-lacZ-SIN vectors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17203107     DOI: 10.1038/sj.gt.3302890

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  9 in total

1.  Immunisation with foamy virus Bet fusion proteins as novel strategy for HIV-1 epitope delivery.

Authors:  Michael Mühle; Kerstin Hoffmann; Martin Löchelt; Joachim Denner
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

2.  Interspecies transmission of simian foamy virus in a natural predator-prey system.

Authors:  Fabian H Leendertz; Florian Zirkel; Emmanuel Couacy-Hymann; Heinz Ellerbrok; Vladimir A Morozov; Georg Pauli; Claudia Hedemann; Pierre Formenty; Siv Aina Jensen; Christophe Boesch; Sandra Junglen
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

Review 3.  Foamy virus vectors for gene transfer.

Authors:  Grant D Trobridge
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

Review 4.  Feline foamy virus-based vectors: advantages of an authentic animal model.

Authors:  Weibin Liu; Janet Lei; Yang Liu; Dragana Slavkovic Lukic; Ann-Mareen Räthe; Qiuying Bao; Timo Kehl; Anne Bleiholder; Torsten Hechler; Martin Löchelt
Journal:  Viruses       Date:  2013-07-12       Impact factor: 5.048

5.  Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.

Authors:  Janet Lei; Wolfram Osen; Adriane Gardyan; Agnes Hotz-Wagenblatt; Guochao Wei; Lutz Gissmann; Stefan Eichmüller; Martin Löchelt
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

6.  Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees.

Authors:  Weimin Liu; Michael Worobey; Yingying Li; Brandon F Keele; Frederic Bibollet-Ruche; Yuanyuan Guo; Paul A Goepfert; Mario L Santiago; Jean-Bosco N Ndjango; Cecile Neel; Stephen L Clifford; Crickette Sanz; Shadrack Kamenya; Michael L Wilson; Anne E Pusey; Nicole Gross-Camp; Christophe Boesch; Vince Smith; Koichiro Zamma; Michael A Huffman; John C Mitani; David P Watts; Martine Peeters; George M Shaw; William M Switzer; Paul M Sharp; Beatrice H Hahn
Journal:  PLoS Pathog       Date:  2008-07-04       Impact factor: 6.823

7.  Functions, structure, and read-through alternative splicing of feline APOBEC3 genes.

Authors:  Carsten Münk; Thomas Beck; Jörg Zielonka; Agnes Hotz-Wagenblatt; Sarah Chareza; Marion Battenberg; Jens Thielebein; Klaus Cichutek; Ignacio G Bravo; Stephen J O'Brien; Martin Löchelt; Naoya Yuhki
Journal:  Genome Biol       Date:  2008-03-03       Impact factor: 13.583

Review 8.  Progresses towards safe and efficient gene therapy vectors.

Authors:  Sergiu Chira; Carlo S Jackson; Iulian Oprea; Ferhat Ozturk; Michael S Pepper; Iulia Diaconu; Cornelia Braicu; Lajos-Zsolt Raduly; George A Calin; Ioana Berindan-Neagoe
Journal:  Oncotarget       Date:  2015-10-13

9.  Replacement of feline foamy virus bet by feline immunodeficiency virus vif yields replicative virus with novel vaccine candidate potential.

Authors:  Carmen Ledesma-Feliciano; Sarah Hagen; Ryan Troyer; Xin Zheng; Esther Musselman; Dragana Slavkovic Lukic; Ann-Mareen Franke; Daniel Maeda; Jörg Zielonka; Carsten Münk; Guochao Wei; Sue VandeWoude; Martin Löchelt
Journal:  Retrovirology       Date:  2018-05-16       Impact factor: 4.602

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.